Skip to content

Adrenal diseases and related complications

Adrenal diseases and related complications

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031792
Enrollment
Unknown
Registered
2020-04-10
Start date
2020-04-20
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism

Interventions

Adrenal disease group:N/A
Primary hypertension group:N/A
Healthy group without hypertension:N/A

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Included cases were males and females aged 18-75 years. 2. Subjects with adrenal hypertension (including primary aldosteronism, Cushing syndrome, pheochromocytoma) diagnosed in the outpatient or ward of Department of Endocrinology and Metabolism, West China Hospital; 3. Agree to participate in this study and carry out one or more of the above tests.

Exclusion criteria

Exclusion criteria: 1. There are heart diseases or chronic kidney diseases caused by other causes. 2. Female subjects are pregnant (serum/urine hCG positive women with fertility potential) or breastfeeding, or plan to become pregnant before, during or within six months after the study, or plan to donate eggs during that period; 3. Those with metal foreign bodies (such as pacemakers, nerve stimulators, artificial metal heart valves, etc.); those with aneurysm clips; those with intraocular metal foreign bodies, inner ear implants, metal prostheses, metal prostheses, metal joints, ferromagnetic foreign bodies in vivo); 4. Allergy to contrast media. 5. Severe hepatorenal insufficiency (TB > 171 umol/L, or AST/ALT > 1; CR > 176.8 umol/L).

Design outcomes

Primary

MeasureTime frame
Cardiac magnetic resonance;echocardiography;

Secondary

MeasureTime frame
Routine blood test;Routine urine test;Dynamic ECG;electrocardiogram;Homocysteine;Nephrosis index;Serum cystatin C;Serum urinary natriuretic;Myocardial markers;parathyroid hormone;Electrolyte;inflammatory factors;

Countries

China

Contacts

Public ContactYan Ren

Department of Endocrinology and Metabolism, West China Hospital, Sichuan University

renyan@scu.edu.cn+86 18980601310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026